[stock-market-ticker symbols=" ^NYA;CRYPTO:BTC;CRYPTO:ETH;CRYPTO:USDT;CRYPTO:USDC;CRYPTO:BNB;CRYPTO:ADA;CRYPTO:XRP;CRYPTO:SOL;CRYPTO:DOGE " stockExchange="NYSENASDAQ" width="100%" transparentbackground=1 palette="financial-light"]

Dave Frederickson

AstraZeneca Targeting $80 Billion in Revenue by 2030 as AI Accelerates Drug Discovery

Dave Frederickson, Executive Vice-President, Oncology Business Unit at AstraZeneca, joins Remy Blaire to highlight AstraZeneca's significant presence on the New York Stock Exchange, boasting...